... that's how long I've been a holder of this stock. I bought my first shares almost 1.5 years ago, in March of 2012 for over $.60. I then saw it fall all the way down to the teens just weeks later. Did I sell? Absolutely not. I kept buying more, and more, and more, until I had my average down into the low .20's.
I've made it this far, and I'm not going anywhere. Sure, I may make some lucrative trades with it every now and then, but why wouldn't I? My obsession with this stock has allowed me to acquire enough knowledge that would make it silly for me not to, and I always make sure to hold onto a certain amount, so I'm not "caught with my #$%$ over the john when I hear the ice cream truck pull up" (I took that quote from waitforit - love it!)
Thanks to all of you who replied to my last post with words of wisdom, and productive feedback. It's obvious that this MB has a solid core of investors with solid minds that can see this situation from all perspectives. If we stick together and share our knowledge & experience, we will all have something to celebrate one day. When this baby breaks the 1 billion dollar market cap, we're gonna have to arrange a big party. VEGAS?!?
Way to go taghova!! I keep a core amount at all times, but like the long term outlook of ONCS a lot. my cost basis is about $0.22 and wont be selling any time soon.
Sentiment: Strong Buy
I think INO is very solid. Tremendous management, and a huge pipeline. I've traded it several times for good profits, but currently don't hold any shares. IMO, it's got less upside vs. ONCS, mostly because it's PPS is 5x higher. However, it's a less risky stock, and for those who want to invest in a company for long-term reward, INO is a great pick.
taghova whats your opinion on this company versus ziopharms valuation where the are worth 240m and this one is worth 33m perhaps their viral vector is competitive with this approach and plus they do not need a bulky electroporation device
maybe this is why market sentiment is so high for them right now instead of us
The seeking alpha article that chemistfrog wrote discussed this as has been pointed out to you already.
In that article he discussed Inovio's results from comparing a viral vector to electroporation and the vector didn't match up. If you believe Inovio's research, or chemistfrog or both, the answer to this same question you keep asking and being answered is still "no" the viral vector platform is not as efficient and is not competitive with electroporation.
Yep, I'm here to stay...I would love to take this chance to add more but I think I'm as deep as I'll go for this stock(added 45,000 last week)
Wifes closing on a new house for us next week, guess i should leave a little in my bank account
I like this stock also but you might want to consider adding another 45,000 because after a possible 1 for 125 reverse split, your 45,000 would be reduced to 360 shares (although at a much nicer price). I recently experienced something similar with ADXS.
Sentiment: Strong Buy
here to stay with almost 100.000 shares. I would only buy more if it drops to 20 or less...which absolutely will not happen (i hope!).
We are here for the long run... I kept buying INO and look what happened... almost 200% since bottoming. Awesome! ;)